Spruce Biosciences, Inc. (SPRB)
OTCMKTS · Delayed Price · Currency is USD
0.0640
+0.0034 (5.61%)
Jun 6, 2025, 11:01 AM EDT

Spruce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-55.45-53.04-47.92-46.18-42.29-29.54
Upgrade
Depreciation & Amortization
0.040.050.070.070.070.04
Upgrade
Loss (Gain) From Sale of Assets
0000.04--
Upgrade
Loss (Gain) From Sale of Investments
---0.640.020.12-
Upgrade
Stock-Based Compensation
4.335.354.623.633.960.76
Upgrade
Other Operating Activities
0.090.250.23-0.40.310.07
Upgrade
Change in Accounts Payable
-0.01-2.041.91-1.4-0.813.73
Upgrade
Change in Unearned Revenue
-2.91-4.914.91---
Upgrade
Change in Other Net Operating Assets
0.18-1.623.542.532.76-2.57
Upgrade
Operating Cash Flow
-53.73-55.96-33.28-41.68-35.88-27.52
Upgrade
Capital Expenditures
---0.01-0.01-0.09-0.07
Upgrade
Investment in Securities
--55.7823.7-79.08-
Upgrade
Investing Cash Flow
--55.7823.69-79.17-0.07
Upgrade
Long-Term Debt Issued
----5-
Upgrade
Long-Term Debt Repaid
--1.62-1.62--4.77-
Upgrade
Net Debt Issued (Repaid)
-1.62-1.62-1.62-0.23-
Upgrade
Issuance of Common Stock
0.070.2553.790.080.4693.4
Upgrade
Repurchase of Common Stock
-0.24-0.25-0.31-0.04--
Upgrade
Other Financing Activities
-0.01--2.72-0.28-0.05-
Upgrade
Financing Cash Flow
-1.81-1.6249.14-0.240.64181.04
Upgrade
Net Cash Flow
-55.54-57.5971.64-18.23-114.4153.44
Upgrade
Free Cash Flow
-53.73-55.96-33.28-41.69-35.97-27.59
Upgrade
Free Cash Flow Margin
-1847.13%-1139.56%-329.88%---
Upgrade
Free Cash Flow Per Share
-1.28-1.36-0.86-1.77-1.54-4.61
Upgrade
Cash Interest Paid
0.230.230.370.270.210.19
Upgrade
Levered Free Cash Flow
-34.78-38.75-17.52-25.55-20.7-16.48
Upgrade
Unlevered Free Cash Flow
-34.62-38.56-17.22-25.28-20.49-16.28
Upgrade
Change in Net Working Capital
2.738.86-10.59-0.57-1.87-1.39
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.